Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma.

Front Oncol · 2025 · PMC12370741 · PMID 40860828

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Prognostic factors Age approached but did not reach statistical significance in terms of PFS, with a three-year PFS rate for patients aged less than 3 of 50% (95% CI: 29.6–84.4) compared to 20% (95% CI: 13.7–29.1) for those three years and above (p = 0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.